Intravascular substance P dilates cerebral parenchymal vessels through a specific tachykinin NK1 receptor in cats

European Journal of Pharmacology

Volumn 317, Issue 2-3, 1996, Pages 269-274

  Kobari, Masahiro ^a   Tomita, Minoru ^a   Tanahashi, Norio ^a   Yokoyama, Masako ^a   Takao, Masaki ^a   Fukuuchi, Yasuo ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Cerebral blood volume; Cerebral vessel; FK888; Photoelectric method; Substance P; Tachykinin NK1 receptor antagonist

Indexed keywords

N BENZYL N2 [4 HYDROXY 1 [(1 METHYL 1H INDOL 3 YL)CARBONYL]PROLYL] N METHYL 3 (2 NAPHTHYL)ALANINAMIDE; SUBSTANCE P; TACHYKININ RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL TONE; BRAIN BLOOD VOLUME; CAT; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; VASODILATATION;

ANIMALS; BLOOD PRESSURE; BLOOD VOLUME; CAROTID ARTERIES; CATS; CEREBROVASCULAR CIRCULATION; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; INDOLES; INJECTIONS, INTRA-ARTERIAL; MICROCIRCULATION; RECEPTORS, NEUROKININ-1; SUBSTANCE P; VASODILATOR AGENTS;

EID: 0030593907     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00725-X     Document Type: Article

References (37)

1. Aramori, I., N. Morikawa, J. Zenkoh, N. O'Donnell, M. Iwami, H. Kojo, Y. Notsu, M. Okuhara, S. Ono and S. Nakanishi, 1994, Subtype- and species-selectivity of a tachykinin receptor antagonist, FK888, for cloned rat and human tachykinin receptors, Eur. J. Pharmacol. 269, 277.
2. Barzó, P., F. Bari, T. Dóczi, G. Jancsó and M. Bodosi, 1993, Significance of the rate of systemic change in blood pressure on the short-term autoregulatory response in normotensive and spontaneously hypertensive rats, Neurosurgery 32, 611.
3. Beattie, D.T., D.K. McNeil and H.E. Connor, 1993a, The influence of neurokinins and calcitonin gene-related peptide on cerebral blood flow in anaesthetized guinea-pig, Neuropeptides 24, 343.
4. Beattie, D.T., C.M. Stubbs, H.E. Connor and W. Feniuk, 1993b, Neurokinin-induced changes in pial artery diameter in the anaesthetized guinea-pig, Br. J. Pharmacol. 108, 146.
5. Edvinsson, L. and I. Jansen, 1987, Characterization of tachykinin receptors in isolated basilar arteries of guinea-pig, Br. J. Pharmacol. 90, 553.
6. Edvinsson, L., J. McCulloch and R. Uddman, 1981, Substance P: immunohistochemical localization and effect upon cat pial arteries in vitro and in situ, J. Physiol. 318, 251.
7. 7,9)-substance P of the cerebrovascular dilatation induced by substance P, Acta Physiol. Scand. 116, 411.
8. Edvinsson, L., J. McCulloch and R. Uddman, 1982b, Feline cerebral veins and arteries: comparison of autonomic innervation and vasomotor responses, J. Physiol. 325, 161.
9. Edvinsson, L., B.B. Fredholm, E. Hamel, I. Jansen and C. Verrecchia, 1985, Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat, Neurosci. Lett. 58, 213.
10. Edvinsson, L., E. Brodin, I. Jansen and R. Uddman, 1988, Neurokinin A in cerebral vessels: characterization, localization and effects in vitro, Regul. Pept. 20, 181.
11. 1 receptor antagonist, FK888, Br. J. Pharmacol. 107, 785.
12. Hallberg, D. and B. Pernow, 1975, Effect of substance P on various vascular beds in the dog, Acta Physiol. Scand. 93, 277.
13. Hökfelt, T., J.-O. Kellerth, G. Nilsson and B. Pernow, 1975, Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons, Brain Res. 100, 235.
14. Kobari, M., J.S. Meyer, M. Ichijo, A. Imai and W.T. Oravez, 1989, Hyperperfusion of cerebral cortex, thalamus and basal ganglia during spontaneously occurring migraine headaches, Headache 29, 282.
15. Kobari, M., J.S. Meyer and M. Ichijo, 1990, Cerebral hemodynamic changes during migraine and cluster headaches: pharmacological implications, Headache Q. Curr. Treat. Res. 1, 23.
16. Kobari, M., Y. Fukuuchi, M. Tomita, N. Tanahashi, T. Shinohara, T. Yamawaki, K. Ohta and H. Takeda, 1992, Cerebral microcirculatory changes during and following transient ventricular tachycardia in cats, J. Neurol. Sci. 111, 153.
17. Kobari, M., Y. Fukuuchi, M. Tomita, N. Tanahashi, S. Konno and H. Takeda, 1994a, Constriction/dilatation of the cerebral microvessels by intravascular endothelin-1 in cats, J. Cereb. Blood Flow Metab. 14, 64.
18. Kobari, M., Y. Fukuuchi, M. Tomita, N. Tanahashi and H. Takeda, 1994b, Role of nitric oxide in regulation of cerebral microvascular tone and autoregulation of cerebral blood flow in cats, Brain Res. 667, 255.
19. Kobari, M., Y. Fukuuchi, M. Tomita, N. Tanahashi, H. Takeda and M. Yokoyama, 1995, Calcitonin gene-related peptide (CGRP) and the regulation of cerebral parenchymal vessels, Brain Res. 698, 95.
20. Liu-Chen, L.-Y., M.R. Mayberg and M.A. Moskowitz, 1983, Immunohistochemical evidence for a substance P-containing trigeminovascular pathway to pial arteries in cats, Brain Res. 268, 162.
21. Macfarlane, R., E. Tasdemiroglu, M.A. Moskowitz, Y. Uemura, E.P. Wei and H.A. Kontos, 1991, Chronic trigeminal ganglionectomy or topical capsaicin application to pial vessels attenuates postocclusive cortical hyperemia but does not influence postischemic hypoperfusion, J. Cereb. Blood Flow Metab. 11, 261.
22. Maggio, J.E., 1988, Tachykinins, Annu. Rev. Neurosci. 11, 13.
23. Markowitz, S., K. Saito and M.A. Moskowitz, 1987, Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain, J. Neurosci. 7, 4129.
24. McCulloch, J., R. Uddman, T.A. Kingman and L. Edvinsson, 1986, Calcitonin gene-related peptide: functional role in cerebrovascular regulation, Proc. Natl. Acad. Sci. USA 83, 5731.
25. Mejia, J.A., J. Pernow, H. von Holst, A. Rudehill and J.M. Lundberg, 1988, Effects of neuropeptide Y, calcitonin gene-related peptide, substance P, and capsaicin on cerebral arteries in man and animals, J. Neurosurg. 69, 913.
26. Moskowitz, M.A. and R. Macfarlane, 1993, Neurovascular and molecular mechanisms in migraine headaches, Cerebrovasc. Brain Metab. Rev. 5, 159.
27. Rosenblum, W.I., T. Shimizu and G.H. Nelson, 1993, Endothelium-dependent effects of substance P and calcitonin gene-related peptide on mouse pial arterioles, Stroke 24, 1043.
28. 133Xe inhalation method, Headache 18, 122.
29. Samnegård, H., L. Thulin, G. Tydén, C. Johansson, O. Muhrbeck and C. Björklund, 1978, Effect of synthetic substance P on internal carotid artery blood flow in man, Acta Physiol. Scand. 104, 491.
30. Shiokawa, Y., J.J. Holst, J. Torben, N. Rasmussen, P. Schmidt and N.-A. Svendgaard, 1993, Cerebrovascular changes following administration of gammaglobulins against substance P or calcitonin gene related peptide in monkey with subarachnoid haemorrhage, Br. J. Neurosurg. 7, 507.
31. Stubbs, C.M., G.J. Waldron, H.E. Connor and W. Feniuk, 1992, Characterization of the receptor mediating relaxation to substance P in canine middle cerebral artery: no evidence for involvement of substance P in neurogenically mediated relaxation, Br. J. Pharmacol. 105, 875.
32. Suzuki, N., J.E. Hardebo and Ch. Owman, 1989, Origins and pathways of cerebrovascular nerves storing substance P and calcitonin gene-related peptide in rat, Neuroscience 31, 427.
33. Tomita, M., F. Gotoh, T. Sato, T. Amano, N. Tanahashi, K. Tanaka and M. Yamamoto, 1978, Photoelectric method for estimating hemodynamic changes in regional cerebral tissue, Am. J. Physiol. 235, H56.
34. Tomita, M., F. Gotoh, T. Amano, N. Tanahashi, M. Kobari, T. Shinohara and B. Mihara, 1983, Transfer function through regional cerebral cortex evaluated by a photoelectric method, Am. J. Physiol. 245, H385.
35. 2 clearance method for measuring cerebrocortical blood flow in cats, J. Cereb. Blood Flow Metab. 8, 727.
36. Uddman, R., L. Edvinsson, R. Ekman, T. Kingman and J. McCulloch, 1985, Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P, Neurosci. Lett. 62, 131.
37. Watling, K.J., 1992, Nonpeptide antagonists herald new era in tachykinin research, Trends Pharmacol. Sci. 13, 266.